clinical trial · NCT00837369
Regadenoson R-T Perfusion Imaging Trial
University of Nebraska·phase1·completed·n = 100
Coronary Artery DiseaseMyocardial Perfusion AbnormalitiesRegadenoson
brief summary
To exam the feasibility and accuracy of Regadenoson real time perfusion (RTPE) Imaging during vasodilator stress with Regadenoson for detection of significant coronary artery disease (CAD) in patients scheduled to undergo coronary angiography.
started
Apr 7, 2009
primary completion
Mar 1, 2011
completion
Dec 1, 2011
last updated
Dec 27, 2024
detailed description
To exam the feasibility and accuracy of RTPE during vasodilator stress with 400micrograms of the adenosine receptor (A2A) agonist Regadenoson for detection of significant coronary artery disease (CAD) in patients scheduled to undergo coronary angiography. Sensitivity, specificity , and accuracy of perfusion and wall motion analysis to identify a coronary stenosis\> 50% in diameter by quantitive angiography will be analyzed
official title
Regadenoson Real Time Perfusion Imaging Trial
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol